Anthem Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	430,278	368,557	-	-	-	-
Enterprise Value	421,429	359,342	-	-	-	-
Last Close Price	766.15	656.30	-	-	-	-
PE Ratio	72.71	62.28	-	-	-	-
PS Ratio	20.25	17.35	-	-	-	-
PB Ratio	14.14	12.11	-	-	-	-
P/TBV Ratio	14.14	12.12	-	-	-	-
P/FCF Ratio	67.94	58.20	-	-	-	-
P/OCF Ratio	50.95	43.64	-	-	-	-
EV/Sales Ratio	19.84	16.92	-	-	-	-
EV/EBITDA Ratio	50.54	43.10	-	-	-	-
EV/EBIT Ratio	60.23	51.35	-	-	-	-
EV/FCF Ratio	66.54	56.74	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.05	0.12	0.07	0.04
Debt / EBITDA Ratio	0.06	0.06	0.17	0.47	0.29	0.10
Debt / FCF Ratio	0.09	0.09	1.09	-	1.08	0.33
Net Debt / Equity Ratio	-0.29	-0.29	-0.26	-0.21	-0.41	-0.41
Net Debt / EBITDA Ratio	-1.06	-1.06	-0.92	-0.80	-1.63	-0.96
Net Debt / FCF Ratio	-1.40	-1.40	-5.96	2.70	-6.06	-3.12
Asset Turnover	0.68	0.68	0.71	0.64	0.58	0.94
Inventory Turnover	3.49	3.49	2.83	3.67	3.81	9.15
Quick Ratio	4.70	4.70	3.65	3.35	6.78	4.18
Current Ratio	5.54	5.54	5.32	4.38	8.07	4.83
Return on Equity (ROE)	21.71%	21.71%	20.82%	20.04%	24.88%	39.44%
Return on Assets (ROA)	14.02%	14.02%	14.12%	12.03%	12.81%	24.49%
Return on Invested Capital (ROIC)	25.20%	25.46%	24.40%	25.61%	31.47%	56.74%
Return on Capital Employed (ROCE)	22.50%	22.50%	23.70%	20.60%	20.10%	37.30%
Earnings Yield	1.38%	1.61%	-	-	-	-
FCF Yield	1.47%	1.72%	-	-	-	-
Buyback Yield / Dilution	-1.04%	-1.04%	0.96%	0.61%	0.00%	-4.33%